Anagenex is building a novel platform for drug discovery focusing on difficult targets.

Anagenex's technology analyzes 100-1000x more compounds compared to traditional approaches by combining machine learning with DNA Encoded Libraries.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2019

• Founders

  • Nicolas Tilmans, PhD
  • Zavain Dar

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • Thrilled to be a part of this year’s @stateofaireport by @nathanbenaich and @soundboy. There's a lot going on in AI… https://t.co/BrcdiWIq5F@anagenex - 04:59 PM Oct 12th
  • Welcome to @Edsn_Aguiar , our first hire in DevOps! He has worked on numerous containerization, automation and orch… https://t.co/2R94XGhNjD@anagenex - 04:12 PM Oct 1st
  • Welcome to @barb_ernisse as our Director of Lab Operations. Barb has seen all aspects of the lab from bench researc… https://t.co/ZTSsmrYOvi@anagenex - 05:31 PM Sep 22nd